A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency

TransCon growth hormone is a sustained-release human growth hormone prodrug under development in which unmodified growth hormone is transiently linked to a carrier molecule. It is intended as an alternative to daily growth hormone in the treatment of growth hormone deficiency. This was a multi-cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Pfeiffer, Andreas F H, Ferone, Diego, Christiansen, Jens Sandahl, Gilfoyle, David, Christoffersen, Eva Dam, Mortensen, Eva, Leff, Jonathan A, Beckert, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424766/
https://www.ncbi.nlm.nih.gov/pubmed/28196799
http://dx.doi.org/10.1530/EC-17-0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424766/
https://www.ncbi.nlm.nih.gov/pubmed/28196799
http://dx.doi.org/10.1530/EC-17-0007

Ejemplares similares